ES2058479T3 - Compuestos peptidicos. - Google Patents

Compuestos peptidicos.

Info

Publication number
ES2058479T3
ES2058479T3 ES89202310T ES89202310T ES2058479T3 ES 2058479 T3 ES2058479 T3 ES 2058479T3 ES 89202310 T ES89202310 T ES 89202310T ES 89202310 T ES89202310 T ES 89202310T ES 2058479 T3 ES2058479 T3 ES 2058479T3
Authority
ES
Spain
Prior art keywords
peptidic compounds
derivatives
pentapeptides
termini
inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89202310T
Other languages
English (en)
Inventor
Ole Didrik Laerum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hafslund Nycomed AS
Original Assignee
Hafslund Nycomed AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hafslund Nycomed AS filed Critical Hafslund Nycomed AS
Application granted granted Critical
Publication of ES2058479T3 publication Critical patent/ES2058479T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722G-proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PEPTIDOS Y DERIVADOS DEL MISMO INCLUYNEDO DERIVADOS QUE TIENEN UNO O MAS ACIDOS AMINOS ADICIONALES INSERTADOS EN LA SECUENCIA Y/O A/ADIDOS AL TERMINO -N Y -C HA DISO DECUBIERTO QUE POSEEN UNA BUENA ACTIVIDAD DE INHIBICION DE LA PROLIFERACION DEL RESTA/EO DE CELULAS. EN ADICION GRUPOS NUEVOS PEPTIDOS SON DESVELADOS Y TIENEN ACCIONES INHIBIDORAS MEJORADAS.
ES89202310T 1988-09-16 1989-09-13 Compuestos peptidicos. Expired - Lifetime ES2058479T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888821785A GB8821785D0 (en) 1988-09-16 1988-09-16 Peptide compounds

Publications (1)

Publication Number Publication Date
ES2058479T3 true ES2058479T3 (es) 1994-11-01

Family

ID=10643722

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89202310T Expired - Lifetime ES2058479T3 (es) 1988-09-16 1989-09-13 Compuestos peptidicos.

Country Status (22)

Country Link
US (1) US5484770A (es)
EP (2) EP0359338B1 (es)
JP (1) JPH04500666A (es)
KR (1) KR900701828A (es)
CN (1) CN1041159A (es)
AT (1) ATE110742T1 (es)
AU (1) AU641366B2 (es)
CA (1) CA1339947C (es)
DE (1) DE68917837T2 (es)
DK (1) DK39591A (es)
ES (1) ES2058479T3 (es)
GB (1) GB8821785D0 (es)
GE (1) GEP19971041B (es)
HU (2) HU895788D0 (es)
IE (1) IE64181B1 (es)
LT (1) LT3714B (es)
LV (1) LV10108B (es)
MY (1) MY104909A (es)
NZ (1) NZ230654A (es)
RU (1) RU2079509C1 (es)
WO (1) WO1990002753A1 (es)
ZA (1) ZA896980B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620957A (en) * 1989-07-14 1997-04-15 Smithkline Beecham Corporation Hemoregulatory peptides
HU206372B (en) * 1990-09-03 1992-10-28 Richter Gedeon Vegyeszet Process for producing new oligopeptides which selectively inhibit proliferation of haemopoietic cells and pharmaceutical compositions comprising same
HU206374B (en) * 1990-09-03 1992-10-28 Richter Gedeon Vegyeszet Process for producing pentapeptide and its salts specifically inhibiting proliferation of epidermic cells, as well as pharmaceutical compositions comprising same as active ingredient
TW222280B (es) * 1991-11-26 1994-04-11 Smithkline Beecham Corp
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9211674D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211668D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211677D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GR1001502B (el) * 1992-11-26 1994-02-28 Smithkline Beecham Corp Αιμορυ?μιστικά πεπτίδια.
CN1034735C (zh) * 1993-01-02 1997-04-30 史密丝克莱恩比彻姆公司 血调节肽
US5521284A (en) * 1994-08-01 1996-05-28 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide amides and esters
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters
CN1403474A (zh) * 2001-09-05 2003-03-19 中国人民解放军军事医学科学院生物工程研究所 一种短肽及以其为活性成份的药物
TWI325003B (en) * 2002-07-23 2010-05-21 Sod Conseils Rech Applic Ghrelin analogs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA838780B (en) * 1982-11-26 1985-01-30 Nyegaard & Co As Peptide compounds
NO860752L (no) * 1985-06-26 1986-12-29 Bio Tech As Pentapeptider med cellevekstregulerende virkning og fremgangsmaate for fremstilling derav.
US4748154A (en) * 1985-12-24 1988-05-31 Takeda Chemical Industries, Ltd. Peptide derivatives, their production and use
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds

Also Published As

Publication number Publication date
LV10108B (en) 1994-10-20
GEP19971041B (en) 1997-11-26
LT3714B (en) 1996-02-26
AU641366B2 (en) 1993-09-23
HU208027B (en) 1993-07-28
WO1990002753A1 (en) 1990-03-22
LV10108A (lv) 1994-05-10
JPH04500666A (ja) 1992-02-06
DE68917837D1 (de) 1994-10-06
DE68917837T2 (de) 1994-12-22
US5484770A (en) 1996-01-16
ZA896980B (en) 1990-06-27
CA1339947C (en) 1998-07-07
KR900701828A (ko) 1990-12-04
AU4218389A (en) 1990-04-02
LTIP610A (en) 1994-12-27
NZ230654A (en) 1991-10-25
GB8821785D0 (en) 1988-10-19
EP0434718A1 (en) 1991-07-03
DK39591D0 (da) 1991-03-06
HUT58765A (en) 1992-03-30
ATE110742T1 (de) 1994-09-15
MY104909A (en) 1994-06-30
HU895788D0 (en) 1991-08-28
CN1041159A (zh) 1990-04-11
IE64181B1 (en) 1995-07-12
IE892954L (en) 1990-03-16
RU2079509C1 (ru) 1997-05-20
DK39591A (da) 1991-03-06
EP0359338A1 (en) 1990-03-21
EP0359338B1 (en) 1994-08-31

Similar Documents

Publication Publication Date Title
CA2270289A1 (en) Proteins with enhanced levels of essential amino acids
ATE63748T1 (de) Enzymwiderstandsfaehige immunomodulatorische peptide.
ES2196031T3 (es) Derivados peptidicos terapeutico.
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
ES2058479T3 (es) Compuestos peptidicos.
NO940299L (no) Peptid med organbeskyttende aktivitet
ATE223481T1 (de) Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator
ATE42308T1 (de) Pharmakologisch aktive peptide.
ATE124955T1 (de) Substrat-peptide.
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DK0842193T3 (da) Somatostatin-analoge cykliske peptider med hæmmende aktivitet på væksthormon
ATE293163T1 (de) Cyclin e spezifische konstrukte und komplexe
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
FR2654430B1 (fr) Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.
ATE310083T1 (de) Deprenyl induziertes protein

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 359338

Country of ref document: ES